08/02/2026
Prescription Peptide Regulatory Update At Element Peptides we support this decision and more like it. As we move out of a dangerous grey market to a more appropriate moderate clinically regulated market. On July 23 and 24, 2026, the FDA’s Pharmacy Compounding Advisory Committee reviewed seven pept...